{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T02:00:07Z","timestamp":1787450407069,"version":"build-2736575974"},"reference-count":30,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1136\/ard.2009.120840","type":"journal-article","created":{"date-parts":[[2010,6,5]],"date-time":"2010-06-05T02:22:01Z","timestamp":1275704521000},"page":"1479-1483","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Predictors of poor response to methotrexate in polyarticular-course juvenile idiopathic arthritis: analysis of the PRINTO methotrexate trial"],"prefix":"10.1016","volume":"69","author":[{"given":"Iris","family":"Vilca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo Garcia","family":"Munitis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Pistorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Ravelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Buoncompagni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanca","family":"Bica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renate","family":"H\u00e4fner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seza","family":"Ozen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Huemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Cheol","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavio","family":"Sztajnbok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Arguedas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Foeldvari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans Iko","family":"Huppertz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luz","family":"Gamir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Magnusson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Dressler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosef","family":"Uziel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion A J","family":"van Rossum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Hollingworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gail","family":"Cawkwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Martini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolino","family":"Ruperto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard.2009.120840_bib1","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1056\/NEJM199204163261602","article-title":"Methotrexate in resistant juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind, placebo-controlled trial. The Pediatric Rheumatology Collaborative Study Group and The Cooperative Children's Study Group","volume":"326","author":"Giannini","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2009.120840_bib2","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1002\/art.20288","article-title":"A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate","volume":"50","author":"Ruperto","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.120840_bib3","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1002\/1529-0131(200008)43:8<1849::AID-ANR22>3.0.CO;2-F","article-title":"Randomized, placebo-controlled, crossover trial of low-dose oral methotrexate in children with extended oligoarticular or systemic arthritis","volume":"43","author":"Woo","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.120840_bib4","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1056\/NEJM200003163421103","article-title":"Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group","volume":"342","author":"Lovell","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2009.120840_bib5","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1002\/art.22838","article-title":"A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis","volume":"56","author":"Ruperto","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.120840_bib6","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0140-6736(08)60998-8","article-title":"Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial","volume":"372","author":"Ruperto","year":"2008","journal-title":"Lancet"},{"key":"10.1136\/ard.2009.120840_bib7","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1056\/NEJMoa0706290","article-title":"Adalimumab with or without methotrexate in juvenile rheumatoid arthritis","volume":"359","author":"Lovell","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2009.120840_bib8","first-page":"1830","article-title":"Methotrexate in juvenile idiopathic arthritis: answers and questions","volume":"27","author":"Ravelli","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2009.120840_bib9","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0022-3476(99)70127-7","article-title":"The extended oligoarticular subtype is the best predictor of methotrexate efficacy in juvenile idiopathic arthritis","volume":"135","author":"Ravelli","year":"1999","journal-title":"J Pediatr"},{"key":"10.1136\/ard.2009.120840_bib10","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1136\/ard.2007.075895","article-title":"Methotrexate improves the health-related quality of life of children with juvenile idiopathic arthritis","volume":"67","author":"C\u00e9spedes-Cruz","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2009.120840_bib11","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/01.bor.0000130286.54383.ea","article-title":"International research networks in pediatric rheumatology: the PRINTO perspective","volume":"16","author":"Ruperto","year":"2004","journal-title":"Curr Opin Rheumatol"},{"key":"10.1136\/ard.2009.120840_bib12","first-page":"1991","article-title":"Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997","volume":"25","author":"Petty","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2009.120840_bib13","first-page":"390","article-title":"International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001","volume":"31","author":"Petty","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2009.120840_bib14","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1002\/1529-0131(199707)40:7<1202::AID-ART3>3.0.CO;2-R","article-title":"Preliminary definition of improvement in juvenile arthritis","volume":"40","author":"Giannini","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.120840_bib15","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1136\/ard.2007.073445","article-title":"The magnitude of early response to methotrexate therapy predicts long-term outcome of patients with juvenile idiopathic arthritis","volume":"67","author":"Bartoli","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2009.120840_bib16","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1651-2227.1994.tb18135.x","article-title":"Factors associated with response to methotrexate in systemic-onset juvenile chronic arthritis","volume":"83","author":"Ravelli","year":"1994","journal-title":"Acta Paediatr"},{"key":"10.1136\/ard.2009.120840_bib17","first-page":"297","article-title":"Evaluation of methotrexate in the treatment of juvenile chronic arthritis according to the subtype","volume":"9","author":"Halle","year":"1991","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/ard.2009.120840_bib18","first-page":"1805","article-title":"Course of joint disease in patients with antinuclear antibody-positive juvenile idiopathic arthritis","volume":"32","author":"Felici","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2009.120840_bib19","first-page":"945","article-title":"Long-term health outcomes and quality of life in American and Italian inception cohorts of patients with juvenile rheumatoid arthritis. I. Outcome status","volume":"24","author":"Ruperto","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2009.120840_bib20","first-page":"952","article-title":"Long-term health outcomes and quality of life in American and Italian inception cohorts of patients with juvenile rheumatoid arthritis. II. Early predictors of outcome","volume":"24","author":"Ruperto","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2009.120840_bib21","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1136\/ard.2007.078121","article-title":"A longitudinal analysis of physical functional disability over the course of juvenile idiopathic arthritis","volume":"67","author":"Magni-Manzoni","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2009.120840_bib22","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/art.22473","article-title":"Proxy-reported health-related quality of life of patients with juvenile idiopathic arthritis: the Pediatric Rheumatology International Trials Organization multinational quality of life cohort study","volume":"57","author":"Oliveira","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.120840_bib23","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1002\/art.11337","article-title":"Prognostic factors for radiographic progression, radiographic damage, and disability in juvenile idiopathic arthritis","volume":"48","author":"Magni-Manzoni","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.120840_bib24","first-page":"637","article-title":"Unilateral destructive wrist synovitis in juvenile idiopathic arthritis","volume":"22","author":"Cassone","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/ard.2009.120840_bib25","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1002\/art.10544","article-title":"The early pattern of joint involvement predicts disease progression in children with oligoarticular (pauciarticular) juvenile rheumatoid arthritis","volume":"46","author":"Al-Matar","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2009.120840_bib26","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1053\/berh.2002.0233","article-title":"Long-term outcomes and predictors of outcomes for patients with juvenile idiopathic arthritis","volume":"16","author":"Oen","year":"2002","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1136\/ard.2009.120840_bib27","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0140-6736(07)60363-8","article-title":"Juvenile idiopathic arthritis","volume":"369","author":"Ravelli","year":"2007","journal-title":"Lancet"},{"key":"10.1136\/ard.2009.120840_bib28","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/1529-0131(200001)43:1<22::AID-ANR4>3.0.CO;2-9","article-title":"Factors predicting response to treatment in rheumatoid arthritis: the importance of disease duration","volume":"43","author":"Anderson","year":"2000","journal-title":"Arthritis Rheum"},{"issue":"5 Suppl 35","key":"10.1136\/ard.2009.120840_bib29","first-page":"S50","article-title":"Relative versus absolute goals of therapies for RA: ACR 20 or ACR 50 responses versus target values for \u201cnear remission\u201d of DAS or single measures","volume":"22","author":"Pincus","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/ard.2009.120840_bib30","first-page":"113","article-title":"High dose methotrexate in the treatment of refractory juvenile rheumatoid arthritis","volume":"13","author":"Reiff","year":"1995","journal-title":"Clin Exp Rheumatol"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724193922?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724193922?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2009.120840","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T01:11:15Z","timestamp":1737249075000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724193922"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S0003496724193922"],"URL":"https:\/\/doi.org\/10.1136\/ard.2009.120840","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictors of poor response to methotrexate in polyarticular-course juvenile idiopathic arthritis: analysis of the PRINTO methotrexate trial","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2009.120840","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}